Skip to main content
OpenTrials
Completed

NCT Number: NCT02475018

The Effect of Shuhua Milk Fortified With Plant Sterol Esters on Serum Cholesterol in Human

The purpose of this study is to determine whether YiLi Xinhuo Shuhua Milk is effective in reducing the serum cholesterol in human with hypercholesterolemia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

BaiZhiFang Community Health Service Centre

Beijing, Beijing Municipality, 100053, China

About this study

In a randomized, placebo-controlled double-blind mono-centric study,179 subjects with total cholesterol (TC) level above 5.18mmol/L and triglyceride (TG) level lower than 2.25mmol/L were assigned to 500ml of low lactose milk enriched with 1.58g plant sterol esters or 500ml plain milk without plant sterols (placebo) or without any dairy product consumption (control) for 60 days. Subjects were instructed to maintain stable diet pattern and physical activity. Plasma concentrations of TC,TG,LDL cholesterol(LDL-C) and HDL cholesterol(HDL-C) were measured at initial visits, after 30days and after 60 days. The primary measurement was the change in TC. Secondary measurements were changes in TG,LDL-C and HDL-C.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female subjects, 18-65 yrs;
  • Serum TC ≥5.18mmol/L, and TG≤2.25mmol/L;
  • Normal blood pressure or able to control blood pressure within normal range;
  • Willing to consent to study participation and to comply with study requirements.

Exclusion criteria

  • Pregnant or breastfeeding women;
  • Known allergies to dairy and any substance in the study product.For example lactose intolerance;
  • Any comorbidity that could,in the opinion of the investigator, preclude the subject's ability to successfully and safely complete the study or that may confound study outcomes, including but not limited to cardiac disease, hepatic disease, renal disease, hematopoietic system disease and mental disease;
  • Recent use (within 2 weeks of screening) of any prescription or OTC medication that affects serum total cholesterol or that may confound study outcomes.

Treatment and study plan

Milk fortified with plant sterol esters

Dietary Supplement

250mL of Shuhua milk fortified with plant sterol esters(with plant sterol esters 262mg/100mL) has been taken twice per day. 500mL of Shuhua milk in total has been taken per day during the 60-days intervention.

Plain Milk

Dietary Supplement

250mL of placebo milk (plain milk) has been taken twice per day. 500mL of plain milk in total has been taken per day during the 60-days intervention.

Primary outcomes

  1. Change in Total Cholesterol(TC) during and after intervention

    Time frame: Baseline & 1 months & 2 mongths

Secondary outcomes

  1. Change in Triglyceride(TG) during and after intervention

    Time frame: Baseline & 1 months & 2 mongths

  2. Change in LDL-C level during and after intervention

    Time frame: Baseline & 1 months & 2 mongths

  3. Change in HDL-C level during and after intervention

    Time frame: Baseline & 1 months & 2 mongths

Sponsors and collaborators

Lead sponsor

Inner Mongolia Yili Industrial Group Co., Ltd

Industry

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2015
First posted
Jun 18, 2015
Registry last updated
Jun 18, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.